We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

47 hedge funds and large institutions have $146M invested in Voyager Therapeutics in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $140M → $146M (+$6.9M)

0.2% more ownership

Funds ownership: 41% → 41.19% (+0.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 21

16% less funds holding

Funds holding: 56 → 47 (-9)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
47
Holders Change
-9
Holders Change %
-16.07%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
19
Reduced
21
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$6.72M
2
BlackRock
BlackRock
New York
+$6.45M
3
CC
Casdin Capital
New York
+$1.4M
4
PHS
PFM Health Sciences
California
+$1.35M
5
DCM
DAFNA Capital Management
California
+$865K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$3.54M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.57M
3
DM
Deerfield Management
New York
-$1.43M
4
GC
Globeflex Capital
California
-$732K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$531K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$49.8M -$2.57M -211,800 -5%
BCPEM
2
Bain Capital Public Equity Management
Massachusetts
$20M – – –
PHS
3
PFM Health Sciences
California
$19.8M +$1.35M +111,650 +8%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$13.2M +$6.72M +553,920 +124%
BlackRock
5
BlackRock
New York
$7.09M +$6.45M +531,627 +12,967%
CC
6
Casdin Capital
New York
$6.62M +$1.4M +115,000 +30%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.53M +$430K +35,447 +9%
EAM
8
Eventide Asset Management
Massachusetts
$3.97M – – –
State Street
9
State Street
Massachusetts
$2.19M -$5.44K -448 -0.3%
JP Morgan Chase
10
JP Morgan Chase
New York
$2.16M -$514K -42,357 -21%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$1.74M +$236K +19,450 +17%
DM
12
Deerfield Management
New York
$1.56M -$1.43M -117,647 -50%
AGA
13
Altrinsic Global Advisors
Connecticut
$1.46M +$121K +10,000 +10%
FT
14
Fiduciary Trust
Massachusetts
$1.44M +$211K +17,386 +19%
Northern Trust
15
Northern Trust
Illinois
$1.4M -$4.95K -408 -0.4%
Wells Fargo
16
Wells Fargo
California
$1.11M +$541K +44,599 +114%
DCM
17
DAFNA Capital Management
California
$944K +$865K +71,320 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$827K +$54.8K +4,516 +8%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$785K -$531K -43,764 -42%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$582K +$72.2K +5,952 +16%
PIM
21
Partner Investment Management
California
$452K -$1.37K -113 -0.3%
TCIM
22
TIAA CREF Investment Management
New York
$442K -$56.1K -4,622 -12%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$391K +$359K +29,554 New
Charles Schwab
24
Charles Schwab
California
$383K +$12.4K +1,026 +4%
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$315K -$3.64K -300 -1%
1
2 3

VYGR Hedge Fund Activity: Q1 2017 in Review

47 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2017, worth a combined $146M — up 4.9% from $140M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VYGR and 3 opened new positions — a net loss of 3 holders — while 21 trimmed existing stakes and 19 added.

The largest buyer was Adage Capital Partners, adding an estimated $6.72M. The largest seller was Goldman Sachs, cutting an estimated $3.54M.

  • 47 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2017, down from 56 in Q4 2016.
  • Funds reported $146M of Voyager Therapeutics stock for Q1 2017, up 4.9% quarter-over-quarter.
  • 3 funds opened new Voyager Therapeutics positions in Q1 2017 and 6 closed out, a net change of -3 holders.
  • The largest Voyager Therapeutics buyer in Q1 2017 was Adage Capital Partners, an estimated $6.72M added.
  • The largest Voyager Therapeutics seller in Q1 2017 was Goldman Sachs, an estimated $3.54M sold.

Based on aggregated 13F filings for Q1 2017.